In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis

Brain

Volumn 134, Issue 4, 2011, Pages 1033-1040

  Goffin, Karolien ^a   Van Paesschen, Wim ^a   Van Laere, Koen ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

18F MK 9470; epilepsy; hippocampal sclerosis; positron emission tomography; type 1 cannabinoid receptor

Indexed keywords

CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; MK 9470 F 18; RADIOLIGAND; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BINDING AFFINITY; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOCAL EPILEPSY; HIPPOCAMPAL SCLEROSIS; HUMAN; IN VIVO STUDY; INSULA; MALE; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE EPILEPSY; VOXEL BASED MORPHOMETRY;

ADULT; AGED; BRAIN MAPPING; CLUSTER ANALYSIS; ENDOCANNABINOIDS; EPILEPSY, TEMPORAL LOBE; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; SCLEROSIS;

EID: 79953664433     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq385     Document Type: Article

References (34)

1. Bernhardt BC, Bernasconi N, Concha L, Bernasconi A. Cortical thickness analysis in temporal lobe epilepsy: reproducibility and relation to outcome. Neurology 2010; 74: 1776-84.
2. Blair RE, Deshpande LS, Sombati S, Falenski KW, Martin BR, DeLorenzo RJ. Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. J Pharmacol Exp Ther 2006; 317: 1072-8. (Pubitemid 43764110)
3. Bouvard S, Costes N, Bonnefoi F, Lavenne F, Mauguière F, Delforge J, et al. Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study. Brain 2005; 128: 1330-43. (Pubitemid 40826187)
4. Burns HD, Van Laere K, Sanabria-Bohorquez S, Hamill TG, Bormans G, Eng WS, et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci USA 2007; 104: 9800-5. (Pubitemid 47175347)
5. Chen K, Neu A, Howard AL, Fö ldy C, Echegoyen J, Hilgenberg L, et al. Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J Neurosci 2007; 27: 46-58. (Pubitemid 46089958)
6. Consroe P. Brain cannabinoid systems as targets for the therapy of neurological disorders. Neurobiol Dis 1998; 5: 534-51. (Pubitemid 29075849)
7. Deshpande LS, Blair RE, Ziobro JM, Sombati S, Martin BR, DeLorenzo RJ. Endocannabinoids block status epilepticus in cultured hippocampal neurons. Eur J Pharmacol 2007; 558: 52-9. (Pubitemid 46328867)
8. Di Marzo V, Melck D, Bisogno T, De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 1998; 21: 521-8. (Pubitemid 28555694)
9. Foldy C, Neu A, Jones MV, Soltesz I. Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci 2006; 26: 1465-9. (Pubitemid 43237017)
10. French JA, Williamson PD, Thadani VM, Darcey TM, Mattson RH, Spencer SS, et al. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol 1993; 34: 774-80. (Pubitemid 23357889)
11. Goffin K, Dedeurwaerdere S, Van Laere K, Van Paesschen W. Neuronuclear assessment of patients with epilepsy. Semin Nucl Med 2008; 38: 227-39. (Pubitemid 351726324)
12. Goffin K, Van Paesschen W, Van Laere K. CB1 receptor PET imaging as biomarker for epileptogenesis in rat pilocarpine model of epilepsy. Poster presentation on the annual meeting of the American Epilepsy Society 2009.
13. Gordon E, Devinsky O. Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. Epilepsia 2001; 42: 1266-72. (Pubitemid 33070666)
14. Hammers A, Asselin MC, Hinz R, Kitchen I, Brooks DJ, Duncan JS, et al. Upregulation of opioid receptor binding following spontaneous epileptic seizures. Brain 2007; 130: 1009-16. (Pubitemid 47355596)
15. Hauser WA, Kurland LT. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 1975; 16: 1-66.
16. Hill EL, Gallopin T, Ferezou I, Cauli B, Rossier J, Schweitzer P, Lambolez B. Functional CB1 receptors are broadly expressed in neo-cortical GABAergic and glutamatergic neurons. J Neurophysiol 2007; 97: 2580-9. (Pubitemid 46557693)
17. Hoffman AF, Laaris N, Kawamura M, Masino SA, Lupica CR. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. J Neurosci 2010; 30: 545-55.
18. Hoffman AF, Lupica CR. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J Neurosci 2000; 20: 2470-9. (Pubitemid 30220334)
19. Isnard J, Guenot M, Ostrowsky K, Sindou M, Mauguiere F. The role of the insular cortex in temporal lobe epilepsy. Ann Neurol 2000; 48: 614-23.
20. Ludanyi A, Eross L, Czirjak S, Vajda J, Halasz P, Watanabe M, et al. Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J Neurosci 2008; 28: 2976-90. (Pubitemid 351442292)
21. Lutz B. On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem Pharmacol 2004; 68: 1691-8. (Pubitemid 39278491)
22. Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 2003; 302: 84-8. (Pubitemid 37210691)
23. Mathern GW, Babb TL, Vickrey BG, Melendez M, Pretorius JK. The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain 1995; 118: 105-18.
24. Naderi N, Aziz AF, Shafaghi B, Najarkolaei AH, Motamedi F. Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice. J Neural Transm 2008; 115: 1501-11.
25. Nelissen N, Van Paesschen W, Baete K, Van Laere K, Palmini A, Van Billoen H, et al. Correlations of interictal FDG-PET metabolism and ictal SPECT perfusion changes in human temporal lobe epilepsy with hip-pocampal sclerosis. Neuroimage 2006; 32: 684-95. (Pubitemid 44164630)
26. Ohno-Shosaku T, Tsubokawa H, Mizushima I, Yoneda N, Zimmer A, Kano M. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J Neurosci 2002; 22: 3864-72. (Pubitemid 37465694)
27. Sanabria-Bohorquez SM, Hamill TG, Goffin K, De Lepeleire I, Bormans G, Burns HD, Van Laere K. Kinetic analysis of the cannabinoid-1 receptor PET tracer [(18)F]MK-9470 in human brain. Eur J Nucl Med Mol Imaging 2010; 37: 920-33.
28. Thie JA, Hubner KF, Isidoro FP, Smith GT. A weight index for the standardized uptake value in 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography. Mol Imaging Biol 2007; 9: 91-8. (Pubitemid 46343071)
29. Van Laere K, Goffin K, Casteels C, Dupont P, Mortelmans L, de Hoon J, Bormans G. Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET. Neuroimage 2008; 39: 1533-41.
30. Van Paesschen W, Dupont P, Van Driel G, Van Billoen H, Maes A. SPECT perfusion changes during complex partial seizures in patients with hippocampal sclerosis. Brain 2003; 126: 1103-11. (Pubitemid 36522953)
31. Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 2003; 307: 129-37. (Pubitemid 37151898)
32. Wallace MJ, Martin BR, DeLorenzo RJ. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 2002; 452: 295-301. (Pubitemid 35279432)
33. Wallace MJ, Wiley JL, Martin BR, DeLorenzo RJ. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur J Pharmacol 2001; 428: 51-7. (Pubitemid 32971757)
34. Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science 2002; 296: 678-82.